Inventor · disambiguated record
Herbert Andres
Also filed as: ANDRES HERBERT
23 granted patents·27 pending applications·50 citations·filing 2001–2024
93Inventor score
Files withHOFFMANN LA ROCHE13ROCHE DIAGNOSTICS OPERATIONS9ROCHE DIAGNOSTICS OPERATIONS INC9GENENTECH INC5ANDRES HERBERT4
Top patents by PatentIndex Score
50 records- 0192US7244575B2Soluble complex comprising a retroviral surface glycoproteinROCHE DIAGNOSTICS CORP·Filed 2005·Granted Jul 17, 2007·11 cites·26 claims
- 0287US11971407B2Detection of anti-p53 antibodiesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2022·Granted Apr 30, 2024·1 cites·18 claims
- 0387US7244819B2Fusion polypeptides, vaccines and compositions of FKBP chaperones and target polypeptidesROCHE DIAGNOSTICS OPERATIONS·Filed 2002·Granted Jul 17, 2007·19 cites·20 claims
- 0484US11125695B2Branched-chain amines in electrochemiluminescence detectionROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted Sep 21, 2021·2 cites·15 claims
- 0581US12306185B2Detection of anti-p53 antibodiesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2024·Granted May 20, 2025·0 cites·16 claims
- 0679US9938340B2Amino acid sequence presenting fusion polypeptide and its useHOFFMANN LA ROCHE·Filed 2015·Granted Apr 10, 2018·2 cites·14 claims
- 0779US7731938B2CYFRA 21-1 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2007·Granted Jun 8, 2010·7 cites·3 claims
- 0875US9266962B2Amino acid sequence presenting fusion polypeptide and its useANDRES HERBERT·Filed 2012·Granted Feb 23, 2016·3 cites·1 claims
- 0974US6962982B2Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using themROCHE DIAGNOSTICS CORP·Filed 2002·Granted Nov 8, 2005·4 cites·42 claims
- 1072US9273144B2Antibody specifically binding to insulin-like growth factor-1ROCHE DIAGNOSTICS OPERATIONS·Filed 2013·Granted Mar 1, 2016·1 cites·1 claims
- 1167US12372474B2Branched-chain amines in electrochemiluminescence detectionROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Granted Jul 29, 2025·0 cites·20 claims
- 1265US10647765B2Amino acid sequence presenting fusion polypeptide and its useHOFFMANN LA ROCHE·Filed 2018·Granted May 12, 2020·0 cites·4 claims
- 1364US2013171135A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1464US2013183300A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1564US2013243758A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1663US2013336960A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1763US2014017231A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1863US2014017232A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1963US2013336959A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2063US2014193397A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2163US2014056874A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 2263US2014056875A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 2363US2013344059A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 2463US2014023639A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 2560US2018364230A1DETECTION OF ANTI-p53 ANTIBODIESROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Application pending·0 cites
- 2658US2014056876A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2758US2014023640A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2857US10301383B2Antibody specifically binding to insulin-like growth factor-1ROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Granted May 28, 2019·0 cites·1 claims
- 2957US2013344060A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3056US2015192587A1Use of protein s100a12 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 3156US2009264618A1Compounds With a Branched LinkerANDRES HERBERT·Filed 2009·Application pending·0 cites
- 3255US2017115294A1Use of protein s100a12 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Application pending·0 cites
- 3352US8426167B2Methods for producing fusion polypeptides or enhancing expression of fusion polypeptidesSCHOLZ CHRISTIAN·Filed 2007·Granted Apr 23, 2013·0 cites·15 claims
- 3452US2014341893A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerGENENTECH INC·Filed 2014·Application pending·0 cites
- 3550US2009286328A1Use of protein s100a12 as a marker for colorectal cancerWILD NORBERT·Filed 2008·Application pending·0 cites
- 3650US2004086943A1Compounds with a branched linkerFiled 2001·Application pending·0 cites
- 3749US11644472B2Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillationROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted May 9, 2023·0 cites·9 claims
- 3848US9116156B2ASC as a marker for chronic obstructive pulmonary disease (COPD)ROCHE DIAGNOSTICS OPERATIONS·Filed 2013·Granted Aug 25, 2015·0 cites·16 claims
- 3947US10094826B2Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-PIK3CDROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Granted Oct 9, 2018·0 cites·8 claims
- 4047US7846653B2ASC as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2007·Granted Dec 7, 2010·0 cites·9 claims
- 4146US2007196844A1Protein PDX1 as a marker for breast cancerPESTLIN GABRIELE·Filed 2006·Application pending·0 cites
- 4244US7566542B2Use of protein ASC as a marker for breast cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2006·Granted Jul 28, 2009·0 cites·7 claims
- 4343US8951738B2CYBP as a marker for lung cancerANDRES HERBERT·Filed 2011·Granted Feb 10, 2015·0 cites·14 claims
- 4443US7579158B2Cellular retinoic acid binding protein II as a marker for breast cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2005·Granted Aug 25, 2009·0 cites·6 claims
- 4542US2010159479A1Timp-1 as a marker for colorectal cancerROLLINGER WOLFGANG·Filed 2009·Application pending·0 cites
- 4641US2007184498A1Protein RS15A as a marker for colorectal cancerTACKE MICHAEL·Filed 2006·Application pending·0 cites
- 4740US2006257950A1Use of protein UBC13 as a marker for breast cancerPESTLIN GABRIELE·Filed 2006·Application pending·0 cites
- 4839US10175241B2ASC as a marker for lung cancerANDRES HERBERT·Filed 2010·Granted Jan 8, 2019·0 cites·13 claims
- 4933US2010240068A1Marker panel for colorectal cancerKARL JOHANN·Filed 2010·Application pending·0 cites
- 5028US7897404B2Conjugates of defined stoichiometryROCHE DIAGNOSTICS OPERATIONS·Filed 2001·Granted Mar 1, 2011·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Herbert Andres files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →